St. Jude completes EP MedSystems buy Jul 8, 2008
Little Canada-based medical-device maker St. Jude (NYSE: STJ) said that shareholders of West Berlin, N.J.-based medical device maker EP MedSystems (Nasdaq: EPMD) will receive $3. 00 per share in the deal with the option of receiving cash or St. Jude common stock. (Twin Cities Business Journal, MN)
St. Jude Medical to buy EP MedSystems Apr 10, 2008
Under the terms of the merger agreement between the two medical device companies, EP MedSystems (NASDAQ:EPMD) shareholders will have the option to receive $3 in cash or St. Jude stock for each EP MedSystems share ... Following the close of the transaction, David Bruce, president and CEO of EP MedSystems, is expected to join St. Jude, and EP will become part of St. Jude's atrial fibrillation division ... The sale is subject to certain closing conditions and regulatory approvals, and approval by... (Philadelphia Business Journal, PA)
Medsystems Gets FDA Warning Letter Oct 9, 2006
EP MedSystems, Inc. (). NEW YORK (AP) - In a filing with the Securities and Exchange Commission on Friday, EP Medsystems -- maker of products to diagnose and treat irregular heartbeats -- said the Food and Drug Administration sent it a warning letter about quality system regulations ... Shares of EP Medsystems closed unchanged at $1. (MSN Money)
Medarex Announces Election of Two New Board Members Sep 16, 2006
Prior to joining EGS in 1998, he spent four years in the healthcare practice of McKinsey ny, and prior to McKinsey ny, he held various operating positions with Lederle Laboratories, Progenics Pharmaceuticals, Inc. and Clontech Laboratories, Inc. He presently serves as a director of Stereotaxis, Inc.; EP MedSystems, Inc.; and CryoCath Technologies Inc. and is a member of the Research Development Committee of the Juvenile Diabetes Research Foundation. Mr. Lele received an M.A. in molecular biology... (PR Newswire)
